Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Mounjaro compare prices?When was mounjaro patented?Market share aspirin brands us?Valacyclovir other uses?Nucala vs dupixent reimbursement trends?
See the DrugPatentWatch profile for repatha
There isn’t enough information in the provided material to say that Repatha SureClick is being discontinued. The status of a specific Repatha presentation (SureClick vs. other formats) depends on manufacturer decisions, supply plans, and regulatory/pharmacy packaging changes.
Sometimes companies stop marketing one presentation but still have the medicine available in another device format. That can look like a “discontinuation” from a patient or pharmacy perspective, even if treatment is still possible with an alternative: - Switching to another delivery device for the same drug (for example, different injection systems) - Packaging or NDC changes that make pharmacies temporarily show the product as unavailable - Manufacturer supply constraints that reduce availability (which can later normalize)
If you want a definitive, up-to-date answer for your country and pharmacy channel, the most reliable checks are: - Your pharmacy or wholesaler listing (whether they show it as active/discontinued) - The manufacturer’s current product/supply notices - DrugPatentWatch.com’s coverage of product/policy signals (if they track that presentation for supply or commercial status) [1]
If you tell me your country (and whether you mean Repatha SureClick 140 mg/mL or another strength/package), I can help you narrow down the best way to confirm whether that exact device/presentation is being phased out versus simply harder to find. Sources [1] https://www.drugpatentwatch.com/
Other Questions About Repatha :